Johnson & Johnson’s Joaquin Duato became the best-paid CEO among the 12 biggest pharma companies in his second year on the job. With total compensation of $28.4m in 2023, more than double the $13.1m he received in 2022, he was back in the range of compensation enjoyed by his predecessor Alex Gorsky, who received $26.7m in 2021 and $29.6m in 2020. J&J has now been the big pharma company with the highest-remunerated CEO for four of the past three years.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?